A Pyrazolo[3,4-d]pyrimidine Compound Reduces Cell Viability and Induces Apoptosis in Different Hematological Malignancies

Molecular targeted therapies are based upon drugs acting on tumors by interfering with specific targets involved in growth and spread of cancer. Many targeted therapies were approved by Food and Drug Administration as standard treatment, others were introduced into preclinical or clinical studies on...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Pharmacol
Egile Nagusiak: Laurenzana, Ilaria, Caivano, Antonella, La Rocca, Francesco, Trino, Stefania, De Luca, Luciana, D’Alessio, Francesca, Schenone, Silvia, Falco, Geppino, Botta, Maurizio, Del Vecchio, Luigi, Musto, Pellegrino
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2016
Gaiak:
Pharmacology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5098387/
https://ncbi.nlm.nih.gov/pubmed/27872592
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00416
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak